Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
CES med ; 34(3): 179-187, dic. 2020. tab, graf
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1339473

ABSTRACT

Resumen Las infecciones por Streptococcus pneumoniae se encuentran dentro de las principales causas de muerte por enfermedades inmunoprevenibles en los niños menores de cinco años. Actualmente, existen vacunas conjugadas contra diversos serotipos de S. pneumoniae, por lo que su introducción ha sido una buena estrategia para la inmunización de la población en riesgo, además de contribuir indirectamente con la disminución de la resistencia antimicrobiana. Se realizó una revisión del último reporte disponible de los serotipos de S. pneumoniae circulantes en niños menores de cinco años residentes en Latinoamérica. Los serotipos vacunales 19A, 3, 14, 1 y no vacunal 12F, fueron los más frecuentes. En Latinoamérica la implementación de la vacuna PCV13 sigue siendo una excelente opción; sin embargo, con la introducción de las vacunas conjugadas se ha visto el fenómeno de enfermedad de reemplazo evidenciado con la circulación de diversidad de serotipos no vacunales. Es necesario realizar regularmente estudios epidemiológicos en los países latinoamericanos a fin de monitorear las estrategias de vacunación y el efecto de las vacunas conjugadas en la región.


Abstract Streptococcus pneumoniae infections are among the leading causes of death from vaccine-preventable diseases in children under the age of 5. There are currently conjugated vaccines against several S. pneumoniae serotypes, thus the introduction of this type of vaccine has been a good strategy for immunizing the population at risk, in addition to indirectly contributing to the decrease in antimicrobial resistance. A review of the last available report of circulating S. pneumoniae serotypes in children under five years of age residing in Latin America was performed. Vaccine serotypes 19A, 3, 14, 1 and non-vaccine serotype 12F were the most frequent. In Latin America the implementation of the PCV13 vaccine continues to be an excellent option; however, with the introduction of conjugate vaccines, the phenomenon of replacement disease has been evidenced by the circulation of diverse non-vaccine serotypes. Epidemiological studies in Latin American countries are necessary to monitor vaccination strategies and the effect of conjugate vaccines in the region.

2.
Rev Panam Salud Publica ; 44: e50, 2020.
Article in English | MEDLINE | ID: mdl-32973902

ABSTRACT

OBJECTIVE: To characterize carbapenemase-producing Klebsiella pneumoniae isolated from patients treated at a hospital in Cumaná, Sucre, Venezuela. METHODS: This was a retrospective study conducted at the general hospital in Cumaná where 58 K. pneumoniae strains were analyzed for resistance to antimicrobials, specifically carbapenems, in January - June 2015. Production of metallo-ß-lactamases and serine carbapenemases was determined by the double-disc synergy test, using EDTA-sodium mercaptoacetic acid and 3-aminophenyl boronic acid discs, respectively. Multiplex-PCR was used to detect genes coding for carbapenemases. Molecular typing using ERIC-PCR determined the presence of clones. RESULTS: Four strains of K. pneumoniae resistant to carbapenems were identified. Phenotypic methods for detection of metallo-ß-lactamases and serine carbapenemases were positive, and PCR demonstrated the co-presence of bla NDM and bla KPC genes in all four strains. ERIC-PCR identified two clones circulating in the hospital. CONCLUSIONS: Infection control strategies are needed at the central hospital in Cumaná and its surrounding areas to prevent the spread of these pathogens, especially given the high levels of migration from Venezuela to other countries in South America.

3.
Rev Panam Salud Publica ; 44, sept. 2020
Article in English | PAHO-IRIS | ID: phr-52322

ABSTRACT

[ABSTRACT]. Objective. To characterize carbapenemase-producing Klebsiella pneumoniae isolated from patients treated at a hospital in Cumaná, Sucre, Venezuela. Methods. This was a retrospective study conducted at the general hospital in Cumaná where 58 K. pneumoniae strains were analyzed for resistance to antimicrobials, specifically carbapenems, in January – June 2015. Production of metallo-β-lactamases and serine carbapenemases was determined by the double-disc synergy test, using EDTA-sodium mercaptoacetic acid and 3-aminophenyl boronic acid discs, respectively. Multiplex-PCR was used to detect genes coding for carbapenemases. Molecular typing using ERIC-PCR determined the presence of clones. Results. Four strains of K. pneumoniae resistant to carbapenems were identified. Phenotypic methods for detection of metallo-β-lactamases and serine carbapenemases were positive, and PCR demonstrated the co-presence of blaNDM and blaKPC genes in all four strains. ERIC-PCR identified two clones circulating in the hospital. Conclusions. Infection control strategies are needed at the central hospital in Cumaná and its surrounding areas to prevent the spread of these pathogens, especially given the high levels of migration from Venezuela to other countries in South America.


[RESUMEN]. Objetivo. Caracterizar la Klebsiella pneumoniae productora de carbapenemasa aislada de pacientes tratados en un hospital de Cumaná (Sucre, Venezuela). Métodos. Se hizo un estudio retrospectivo en el hospital central de Cumaná, donde se analizaron 58 cepas de k. pneumoniae para estudiar la resistencia a los antimicrobianos, específicamente a los fármacos carbapenémicos, entre enero y junio del 2015. La producción de metalo-β-lactamasas y carbapenemasas de serina se determinó mediante la prueba de sinergia de doble disco, usando discos de EDTA SMA de sodio y de ácido borónico 3 aminofenil, respectivamente. Se usó la PCR múltiple para detectar la codificación de genes correspondiente a las carbapenemasas. Se determinó la presencia de clones por tipificación molecular mediante la técnica de ERIC PCR. Resultados. Se detectaron cuatro cepas de K. pneumoniae resistentes a los fármacos carbapenémicos. Los métodos fenotípicos para la detección de metalo-β-lactamasas y carbapenemasas de serina fueron positivos y se demostró mediante la PCR la copresencia de los genes blaNDM y blaKPC en las cuatro cepas. Por medio de la técnica ERIC-PCR se detectaron dos clones que circulaban en el hospital. Conclusiones. Es necesario adoptar estrategias de control de infecciones en el hospital central en Cumaná y las zonas circundantes para prevenir la propagación de estos agentes patógenos, especialmente dados los niveles altos de migración de Venezuela a otros países de América del Sur.


[RESUMO]. Objetivo. Caracterizar cepas de Klebsiella pneumoniae produtoras de carbapenemases isoladas de pacientes tratados em um hospital em Cumaná, Sucre, na Venezuela. Métodos. Realizamos um estudo retrospectivo no hospital geral de Cumaná, onde 58 cepas de K. pneumoniae foram analisadas para verificar a resistência a antimicrobianos, especificamente carbapenens, entre janeiro e junho de 2015. A produção de metalo-β-lactamases e serino-carbapenemases foi determinada pelo teste de sinergia de disco duplo, usando discos de EDTA sódico-ácido mercaptoacético e ácido 3-aminofenil borônico, respectivamente. Utilizamos a PCR multiplex para detectar os genes codificadores de carbapenemases. A tipagem molecular por ERIC-PCR determinou a presença de clones. Resultados. Foram identificadas quatro cepas de K. pneumoniae resistentes a carbapenens. Os métodos fenotípicos para a detecção de metalo-β-lactamases e serino-carbapenemases foram positivos, e a PCR demonstrou a co-presença dos genes blaNDM e blaKPC em todas as quatro cepas. A ERIC-PCR identificou dois clones que circulavam no hospital. Conclusões. São necessárias estratégias de controle de infecções no hospital central de Cumaná e seus arredores para prevenir a disseminação destes patógenos, especialmente devido aos altos níveis de migração da Venezuela para outros países da América do Sul.


Subject(s)
Klebsiella pneumoniae , Carbapenem-Resistant Enterobacteriaceae , Molecular Typing , Venezuela , Carbapenem-Resistant Enterobacteriaceae , Molecular Typing , Carbapenem-Resistant Enterobacteriaceae , Molecular Typing
4.
Article in English | MEDLINE | ID: mdl-30970111

ABSTRACT

Multidrug resistance (MDR), virulence and transferable elements potentiate Pseudomonas aeruginosa's role as an opportunistic pathogen creating a high risk for public health. In this study, we evaluated the possible association of multidrug resistance, virulence factors and integrons with intrahospital P. aeruginosa strains isolated from patients at Cumana hospital, Venezuela. Relevant clinical-epidemiological data were collected to study 176 strains (2009-2016) isolated from different hospital units. Bacterial resistance was classified as susceptible, low-level resistant (LDR), multidrug resistant (MDR) and extensively drug-resistant (XDR). Most strains produced pyoverdine, DNase, gelatinase and hemolysin. Around 73% of the strains showed some type of movement. MDR and XDR strains increased from 2009 (24.2% and 4.8%, respectively) to 2016 (53.1% and 18.8%); while LDR decreased from 64.5% to 6.3%. The exoU and exoS genes were found in a significant number of strains (38.1 and 7.4%, respectively). Class I integrons were detected in 35.8% of the strains and the frequency was associated with resistance (42.9, 22.4, 41.4 and 61.9%, for susceptible, LDR, MDR and XDR, respectively). The MDR/XDR strains were positively associated with hemolysins and exoU, but negatively associated with bacterial twitching. MDR/XDR phenotypes were also associated with the Intensive Care Unit (ICU), septicemia, bronchial infection and diabetic foot ulcers, as well as long hospital stay (≥10 days) and previous antimicrobial treatment. High frequency of MDR/XDR strains and their association with class I integrons and virulence factors can increase the infection potential, as well as morbidity and mortality of patients attending this hospital and could spread infection to the community, creating a health risk for the region.


Subject(s)
Anti-Bacterial Agents/pharmacology , Integrons/genetics , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/pathogenicity , Virulence Factors/genetics , Biofilms/growth & development , Drug Resistance, Multiple, Bacterial , Hospitals, University , Humans , Intensive Care Units , Microbial Sensitivity Tests , Phenotype , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/enzymology , Venezuela , Virulence
5.
Rev Chilena Infectol ; 35(2): 147-154, 2018 04.
Article in Spanish | MEDLINE | ID: mdl-29912252

ABSTRACT

BACKGROUND: Enterobacteria resistant to quinolones is increasing worldwide, including Venezuela. The mechanism for this resistance could be due to genes included in the chromosome or in transmissible plasmids. AIM: To evaluate the resistance to quinolones, coded by qnr genes present in enterobacteria species, isolated in the University Hospital of Cumana, Venezuela. METHODS: Antimicrobial susceptibility tests to quinolones, beta-lactams and aminoglycosides were carried out to all the isolates. The presence of qnr genes were determined by PCR. The isolates carrying the qnr genes were used for bacterial conjugation tests to determine the presence of transferable plasmids. Antimicrobial susceptibility tests and PCR were carried out in the transconjugants to verify the transfer of the genes. RESULTS: High levels of antimicrobial resistance to quinolones and beta-lactams were found among the isolates. We found that 33.6% of the isolates carry the qnrB gene and 0.9% qnr A gene. Of the 23 transconjugants, 20 showed to have qnrB gene, but none qnrA. DISCUSSION: We concluded that the high frequency of qnr genes found in the enterobacteria isolates and their presence on transferable plasmids, complicate the use of quinolones for the treatment of bacterial infections, thus, a treatment plan should be designed with the rational use and the rotation of different types of antimicrobials, in order to avoid the selection of increasingly resistant strains.


Subject(s)
Anti-Bacterial Agents/pharmacology , Drug Resistance, Bacterial/genetics , Enterobacteriaceae Infections/genetics , Enterobacteriaceae/genetics , Gram-Negative Bacteria/genetics , Plasmids , Quinolones/pharmacology , beta-Lactam Resistance/genetics , DNA, Bacterial/genetics , Enterobacteriaceae/isolation & purification , Enterobacteriaceae Infections/microbiology , Escherichia coli Proteins , Genes, Bacterial , Gram-Negative Bacteria/classification , Hospitals, University , Microbial Sensitivity Tests , Polymerase Chain Reaction , Sequence Analysis, DNA , Venezuela , beta-Lactamases/genetics
6.
Rev. chil. infectol ; 35(2): 147-154, abr. 2018. tab, graf
Article in Spanish | LILACS | ID: biblio-959424

ABSTRACT

Resumen Introducción: La resistencia de enterobacterias a quinolonas se ha difundido por el mundo, fenómeno presente también en Venezuela. El mecanismo de esta resistencia pudiera estar mediado por genes incluidos en el cromosoma bacteriano o transmitirse en el interior de plásmidos. Objetivo: Evaluar la resistencia a quino-lonas, codificada por genes qnr, presentes en cepas de enterobacterias, aisladas en el Hospital Universitario de Cumaná, Venezuela. Métodos: A las cepas obtenidas se les realizaron pruebas de susceptibilidad antimicrobiana a quinolonas, β-lactámicos y aminoglucósidos. La presencia del gen qnr se determinó por RPC. Las enterobacterias portadoras del gen qnr fueron sometidas al proceso de conjugación bacteriana para comprobar su capacidad de transferencia. A las transconjugantes obtenidas se les realizó pruebas de susceptibilidad antimicrobiana y RPC para comprobar la transferencia de los genes. Resultados: Se encontraron elevados porcentajes de resistencia antimicrobiana a quinolonas y betalactámicos. El 33,6% de las cepas eran portadoras del gen qnrB, y 0,9% del gen qnrA. Se obtuvieron 23 cepas transconjugantes; de éstas, 20 portaban el gen qnrB, no se observó la presencia de qnrA. Discusión: En conclusión, el elevado porcentaje de genes qnr encontrado en las enterobacterias aisladas, y comprobada la presencia de éstos en plásmidos transferibles, complica la aplicación de tratamientos basados en quinolonas y fluoroquinolonas, por lo que es recomendable el uso racional de estos antimicrobianos, y proponer la rotación de la terapia antimicrobiana, a fin de evitar la selección de cepas resistentes.


Background: Enterobacteria resistant to quinolones is increasing worldwide, including Venezuela. The mechanism for this resistance could be due to genes included in the chromosome or in transmissible plasmids. Aim: To evaluate the resistance to quinolones, coded by qnr genes present in enterobacteria species, isolated in the University Hospital of Cumana, Venezuela. Methods: Antimicrobial susceptibility tests to quinolones, beta-lactams and aminoglycosides were carried out to all the isolates. The presence of qnr genes were determined by PCR. The isolates carrying the qnr genes were used for bacterial conjugation tests to determine the presence of transferable plasmids. Antimicrobial susceptibility tests and PCR were carried out in the transconjugants to verify the transfer of the genes. Results: High levels of antimicrobial resistance to quinolones and beta-lactams were found among the isolates. We found that 33.6% of the isolates carry the qnrB gene and 0.9% qnr A gene. Of the 23 transconjugants, 20 showed to have qnrB gene, but none qnrA. Discussion: We concluded that the high frequency of qnr genes found in the enterobacteria isolates and their presence on transferable plasmids, complicate the use of quinolones for the treatment of bacterial infections, thus, a treatment plan should be designed with the rational use and the rotation of different types of antimicrobials, in order to avoid the selection of increasingly resistant strains.


Subject(s)
Plasmids , Quinolones/pharmacology , beta-Lactam Resistance/genetics , Drug Resistance, Bacterial/genetics , Enterobacteriaceae/genetics , Enterobacteriaceae Infections/genetics , Gram-Negative Bacteria/genetics , Anti-Bacterial Agents/pharmacology , Venezuela , beta-Lactamases/genetics , DNA, Bacterial/genetics , Microbial Sensitivity Tests , Polymerase Chain Reaction , Sequence Analysis, DNA , Escherichia coli Proteins , Enterobacteriaceae/isolation & purification , Enterobacteriaceae Infections/microbiology , Genes, Bacterial , Gram-Negative Bacteria/classification , Hospitals, University
7.
Invest. clín ; 57(4): 402-408, dic. 2016. ilus
Article in English | LILACS | ID: biblio-841129

ABSTRACT

Besides the importance of Enterobacter cloacae species complex as a nosocomial pathogen, little is known about the frequency of each species/genotype. Here, we describe a strain of E. hormaechei subsp. hormaechei isolated from a bronchial secretion of a patient, in the Intensive Care Unit at the General Hospital of Cumaná, Venezuela, who died due to complications of his infection. The molecular identification was done by sequencing the 16S rRNA gene and comparing it to sequences from the GenBank. This strain showed resistance to multiple families of antibiotics (MDR), and the genes blaKPC and blaVIM were detected by PCR. This is the first time E. hormaechei has been identified in Venezuela.


A pesar de la importancia de las especies del complejo Enterobacter cloacae como patógeno nosocomial, poco se conoce sobre la frecuencia de cada especie/genotipo. Aquí se describe una cepa de E. hormaechei subsp. hormaechei aislada de una secreción bronquial de un paciente internado en la Unidad de Cuidados Intensivos del Hospital General de Cumaná, Venezuela, quien murió producto de complicaciones de su infección. La identificación molecular fue hecha por secuenciación del gen ARNr 16S y porcomparación con las secuencias del GenBank. Esta cepa mostró resistencia a múltiples familias de antibióticos (MDR) y se detectaron los genes blaKPCyblaVIMpor PCR. Este es el primer reporte de E. hormaechei en Venezuela.


Subject(s)
Humans , Male , Middle Aged , Drug Resistance, Multiple, Bacterial , Enterobacter/classification , Enterobacter/drug effects , Enterobacteriaceae Infections/microbiology , Venezuela , Microbial Sensitivity Tests , Fatal Outcome , Enterobacter/isolation & purification
8.
Rev. chil. infectol ; 33(5): 519-523, oct. 2016. ilus, graf, tab
Article in Spanish | LILACS | ID: biblio-844403

ABSTRACT

In order to study the clonal relationship and blaKPC gene detection in clinical isolates of Klebsiella pneumoniae resistant to carbapenems, we analyzed 22 clinical isolates of K. pneumoniae with resistance to imipenem and/ or meropenem, isolated in the laboratory of bacteriology at the University Hospital "Antonio Patricio de Alcalá" (HUAPA) from the Cumana city, Sucre state, Venezuela, for a period of five consecutive years. Susceptibility to different antimicrobials was determined, and the presence of carbapenemases was detected by modified Hodge method, phenyl boronic acid synergy and combination discs. blaKPC gene detection was conducted by polymerase chain reaction and the clonal relationship was determined by pulsed field electrophoresis. High rates of antimicrobial resistance were found, five strains were negative, at least one phenotypic method, and all carried the blaKPC gene. Clonal spread was observed only in the intensive care unit (ICU), while in other services, polyclonality was found. We concluded that blaKPC gene is present in K. pneumoniae strains resistant to carbapenems isolated in the HUAPA and clonal spread it was only in the ICU.


Con el objetivo de estudiar la relación clonal y detección del gen blaKPC en aislados clínicos de Klebsiella pneumoniae resistentes a carbapenémicos, se analizaron 22 cepas clínicas de K. pneumoniae con resistencia a imipenem y/o meropenem, aisladas en el laboratorio de bacteriología del Hospital Universitario "Antonio patricio de Alcalá" (HUAPA) de la ciudad de cumaná, Estado Sucre, Venezuela, durante un período de cinco años continuos. Se determinó la susceptibilidad a diversos antimicrobianos, y se detectó la presencia de carbapenemasas por los métodos de Hodge modificado, sinergia con ácido fenil borónico y combinación de discos. La detección del gen blaKPC se llevó a cabo mediante la técnica de reacción de polimerasa en cadena y la determinación de la relación clonal se realizó por electroforesis de campo pulsado. Se encontraron elevados porcentajes de resistencia antimicrobiana, cinco cepas resultaron negativas, al menos, a un método fenotípico y todas portaban el gen blaKPC. Se observó diseminación de clones únicamente en la Unidad de cuidados Intensivos (UCI), mientras que, en otros servicios, se halló policlonalidad. Se concluye que el gen blaKPC se encuentra presente en cepas de K. pneumoniae resistentes a carbapenémicos aisladas en el HUAPA y que hubo diseminación clonal sólo en UCI.


Subject(s)
Humans , beta-Lactamases/genetics , Klebsiella Infections/microbiology , Carbapenems/pharmacology , Klebsiella pneumoniae/drug effects , Klebsiella pneumoniae/genetics , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/genetics , Venezuela , DNA, Bacterial/genetics , Microbial Sensitivity Tests , Polymerase Chain Reaction , Electrophoresis, Gel, Pulsed-Field , Clone Cells
9.
Rev Chilena Infectol ; 33(5): 524-530, 2016 Oct.
Article in Spanish | MEDLINE | ID: mdl-28112335

ABSTRACT

In order to study the clonal relationship and blaKPC gene detection in clinical isolates of Klebsiella pneumoniae resistant to carbapenems, we analyzed 22 clinical isolates of K. pneumoniae with resistance to imipenem and/ or meropenem, isolated in the laboratory of bacteriology at the University Hospital "Antonio Patricio de Alcalá" (HUAPA) from the Cumana city, Sucre state, Venezuela, for a period of five consecutive years. Susceptibility to different antimicrobials was determined, and the presence of carbapenemases was detected by modified Hodge method, phenyl boronic acid synergy and combination discs. blaKPC gene detection was conducted by polymerase chain reaction and the clonal relationship was determined by pulsed field electrophoresis. High rates of antimicrobial resistance were found, five strains were negative, at least one phenotypic method, and all carried the blaKPC gene. Clonal spread was observed only in the intensive care unit (ICU), while in other services, polyclonality was found. We concluded that blaKPC gene is present in K. pneumoniae strains resistant to carbapenems isolated in the HUAPA and clonal spread it was only in the ICU.


Subject(s)
Anti-Bacterial Agents/pharmacology , Carbapenems/pharmacology , Klebsiella Infections/microbiology , Klebsiella pneumoniae/drug effects , Klebsiella pneumoniae/genetics , beta-Lactamases/genetics , Bacterial Proteins/genetics , Clone Cells , DNA, Bacterial/genetics , Electrophoresis, Gel, Pulsed-Field , Humans , Microbial Sensitivity Tests , Polymerase Chain Reaction , Venezuela
10.
Invest Clin ; 57(4): 402-8, 2016 Dec.
Article in English | MEDLINE | ID: mdl-29938989

ABSTRACT

Besides the importance of Enterobacter cloacae species complex as a nosocomial pathogen, little is known about the frequency of each species/genotype. Here, we describe a strain of E. hormaechei subsp. hormaechei isolated from a bronchial secretion of a patient, in the Intensive Care Unit at the General Hospital of Cumaná, Venezuela, who died due to complications of his infection. The molecular identification was done by sequencing the 16S rRNA gene and comparing it to sequences from the GenBank. This strain showed resistance to multiple families of antibiotics (MDR), and the genes blaKPC and blaVIM were detected by PCR. This is the first time E. hormaechei has been identified in Venezuela.


Subject(s)
Drug Resistance, Multiple, Bacterial , Enterobacter/classification , Enterobacter/drug effects , Enterobacteriaceae Infections/microbiology , Enterobacter/isolation & purification , Fatal Outcome , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Venezuela
11.
Invest Clin ; 56(2): 182-7, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26299058

ABSTRACT

An 83-year-old male patient is admitted to the central hospital in Cumana, Venezuela with severe urinary infection, history of hospitalizaions and prolonged antimicrobial treatments. A strain of Enterobacter cloacae was isolated showing resistance to multiple types of antibiotics (only sensitive to gentamicin), with phenotype of serine- and metallo-carbapenemases. Both, bla(VIM-2) and bla(KPC) genes were detected in the isolate. This is the first report of an Enterobacteriaceae species producing both KPC carbapenemase and VIM metallo carbapenemase in Venezuela. This finding has a great clinical and epidemiological impact in the region, because of the feasibility of transferring these genes, through mobile elements to other strains of Enterobacter and to other infection-causing species of bacteria.


Subject(s)
Enterobacter cloacae/isolation & purification , Enterobacteriaceae Infections/genetics , beta-Lactamases/genetics , Aged, 80 and over , Anti-Bacterial Agents/pharmacology , Drug Resistance, Multiple, Bacterial , Enterobacter cloacae/genetics , Enterobacteriaceae Infections/drug therapy , Enterobacteriaceae Infections/microbiology , Humans , Male , Urinary Tract Infections/drug therapy , Urinary Tract Infections/microbiology , Venezuela
12.
Invest. clín ; 56(2): 182-187, jun. 2015. ilus, graf
Article in Spanish | LILACS | ID: biblio-841077

ABSTRACT

An 83-year-old male patient is admitted to the central hospital in Cumaná, Venezuela with severe urinary infection, history of hospitalizations and prolonged antimicrobial treatments. A strain of Enterobacter cloacae was isolated showing resistance to multiple types of antibiotics (only sensitive to gentamicin), with phenotype of serine- and metallo-carbapenemases. Both, blaVIM-2 and blaKPC genes were detected in the isolate. This is the first report of an Enterobacteriaceae species producing both KPC carbapenemase and VIM metallo carbapenemase in Venezuela. This finding has a great clinical and epidemiological impact in the region, because of the feasibility of transferring these genes, through mobile elements to other strains of Enterobacter and to other infection-causing species of bacteria.


En un paciente masculino de 83 años, que ingresó al Hospital de Cumaná, Venezuela, con diagnóstico de infección urinaria severa, antecedentes de hospitalización y diferentes tratamientos antimicrobianos durante largos periodos de tiempo, se aisló una cepa de Enterobacter cloacae, la cual evidenció resistencia a múltiples tipos de antibióticos (solo sensible a gentamicina) y con fenotipo de carbapenemasas de tipo serina y metalobetalactamasa. Los genes blaVIM-2 y blaKPC fueron detectados en esta cepa. Este representa el primer reporte de una especie de Enterobacteriaceae productora simultánea de carbapenemasa KPC y metalobetalactamasa VIM en Venezuela. Esto tiene un gran impacto clínico y epidemiológico en la región por la posibilidad de transferencia de estos genes a otras cepas de Enterobacter u otras especies bacterianas causantes de infecciones, por medio de elementos móviles.


Subject(s)
Aged, 80 and over , Humans , Male , beta-Lactamases/genetics , Enterobacter cloacae/isolation & purification , Enterobacteriaceae Infections/genetics , Urinary Tract Infections/microbiology , Urinary Tract Infections/drug therapy , Venezuela , Enterobacter cloacae/genetics , Drug Resistance, Multiple, Bacterial , Enterobacteriaceae Infections/microbiology , Enterobacteriaceae Infections/drug therapy , Anti-Bacterial Agents/pharmacology
13.
Rev Inst Med Trop Sao Paulo ; 56(1): 67-9, 2014.
Article in English | MEDLINE | ID: mdl-24553611

ABSTRACT

Clinical strains of Enterobacter were isolated from Cumana's Central Hospital in Venezuela, and classified as E. cloacae (21), E. aerogenes (7), E. intermedium (1), E. sakazakii (1) and three unclassified. The strains showed high levels of resistance, especially to SXT (58.1%), CRO (48.8%), CAZ (46.6%), PIP (46.4%), CIP (45.2%) and ATM (43.3%). This is the first report for South America of blaVIM-2 in two E. cloacae and one Enterobacter sp., which also showed multiple mechanisms of resistance. Both E. cloacae showed blaTEM-1, but only one showed blaCTX-M-15 gene, while no blaSHV was detected.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacterial Proteins/genetics , Enterobacter , beta-Lactamases/biosynthesis , Cross Infection/microbiology , Enterobacter/drug effects , Enterobacter/enzymology , Enterobacter/genetics , Enterobacteriaceae Infections/microbiology , Humans , Microbial Sensitivity Tests , Venezuela
14.
Rev. Inst. Med. Trop. Säo Paulo ; 56(1): 67-69, Jan-Feb/2014. tab, graf
Article in English | LILACS | ID: lil-702055

ABSTRACT

Clinical strains of Enterobacter were isolated from Cumana's Central Hospital in Venezuela, and classified as E. cloacae (21), E. aerogenes (7), E. intermedium (1), E. sakazakii (1) and three unclassified. The strains showed high levels of resistance, especially to SXT (58.1%), CRO (48.8%), CAZ (46.6%), PIP (46.4%), CIP (45.2%) and ATM (43.3%). This is the first report for South America of blaVIM-2 in two E. cloacae and one Enterobacter sp., which also showed multiple mechanisms of resistance. Both E. cloacae showed blaTEM-1, but only one showed blaCTX-M-15 gene, while no blaSHV was detected.


Cepas clínicas de Enterobacter fueron aisladas del Hospital central de Cumaná en Venezuela, y se clasificaron como E. cloacae (21), E. aerogenes (7), E. intermedium (1), E. sakazakii (1) y 3 sin clasificar. Las cepas mostraron altos niveles de resistencia, especialmente a SXT (58.1%), CRO (48.8%), CAZ (46.6%), PIP (46.4%), CIP (45.2%) and ATM (43.3%). Este es el primer reporte de América del Sur de blaVIM-2 en dos cepas de E. cloacae y una de Enterobacter sp., las cuales también mostraron múltiples mecanismos de resistencia. Ambas especies de E. cloacae mostraron genes blaTEM-1, pero solo una mostro el gen blaCTX-M-15, mientras que blaSHV no fue detectado.


Subject(s)
Humans , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/genetics , Enterobacter , beta-Lactamases/biosynthesis , Cross Infection/microbiology , Enterobacter/drug effects , Enterobacter/enzymology , Enterobacter/genetics , Enterobacteriaceae Infections/microbiology , Microbial Sensitivity Tests , Venezuela
15.
Bol. venez. infectol ; 23(1): 13-19, ene.-jun. 2012. ilus, tab
Article in Spanish | LILACS | ID: lil-721059

ABSTRACT

La resistencia a carbapenems en la familia Enterobacteriaceae constituye un problema creciente a nivel mundial, siendo el mecanismo de mayor impacto clínico, epidemiológico y microbiológico, la producción de serino-carbapenemasas KPC. Investigar la presencia de carbapenemasas tipo KPC en aislados de Enterobacterias resistentes a carbapenems, provenientes de diversos centros de salud a nivel nacional, durante el período mayo 2010 - junio 2011. En esta investigación se analizaron 91 aislados de Enterobacterias: K pneumoniae (48), E. cloacae (30), E. aerogenes (4), E. coli (2), C. koseri (1), C. freundil (6), con resistencia a carbapenems provenientes de 14 centros de salud. La susceptibilidad antimicrobiana se evaluó siguiendo los criterios de la CLSI 2011. La detección fenotípica de carbapenemasas se realizó mediante el test de Hodge modificado y evaluando la sinergia con el ácido 3-aminofenilborónico 300 µg/disco. Se realizó el Test de Hodge "doble modificado" a los aislados de Enterobacter y Citrobacter. La detección genotípica de carbapenemasas se llevó a cabo mediante PCR utilizando iniciadores para el gen blaKPC. Todos los aislados presentaron a los deinhibición < 22 mm para meropenem y ertapenem. El 95% de los aislados resultaron positivos para el test de Hogde modificado, el test con ácido borónico, y para el gen blaKPC. En el test de Hodge "doble modificado", se observó 100% de positividad. La resistencia a carbapenems mediada por Carbapenemasas KPC, se ha incrementado en los últimos años en el país y el carácter plasmídico de estas enzimas les permite su fácil diseminación entre diversos géneros de Enterobacterias.


Resistance to carbapenems is the family Enterobacteriaceae is a growing problem around the world, being production of KPC serino-carbapenemase, the mayor impact clinical, epidemiological and microbiological mechanism. To investigate the presence of KPC carbapenemases in isolates of Enterobacterias resistant to carbapenems, from various health centers nationwide, during the period May-2010 June 2011. In this study were analyzed 91 Enterobacterias isolates: K. pneumoniae (48), E. cloacae (30), E. aerogenes (4), E. coli (2), C. koseri (1), C. freundii (6), with resistance to carbapenems from 14 health centers. Antimicrobial susceptibility was evaluated according to the criteria of the CLSI 2011. Phenotypic detection of carbapenemases was performed by Modified Hodge Test and it was evaluated the synergy with the 3-aminophenylboronic 300 µg/disc. Test were done with "double Modified" Hodge to Enterobacter and Citrobacter isolates. Genotypic detection of carbapenemases was performed out by using PCR primers for the gene blaKPC. All isolated showed inhibition zones <22 mm for meropenem and ertapemen. The 95% of the isolates were positive for Hogde Modified Test, test with boronic acid, and to blaKPC gene. By performing "Double Modified" Hodge`s essay , we observed a 100% of positivity. Resistance to carbapenems mediated by KPC carbapenemases has increased in the last few years in the country, and plasmidic characterization of these enzymes allows easily dissemination among different genera of Enterobacteriaceae.


Subject(s)
Carbapenems/analysis , Carbapenems/radiation effects , Drug Resistance, Microbial , Enterobacteriaceae , Enterobacteriaceae/isolation & purification , Infectious Disease Medicine
SELECTION OF CITATIONS
SEARCH DETAIL
...